Chuck Mattera, PhD
President & CEO
Abstract: Dr. Chuck Mattera will talk with Editor in Chief Conard Holton about the optics, lasers, advanced materials, and
markets that defne the role of II-VI Incorporated in the photonics marketplace. The conversation will explore Dr. Mattera’s
views on the different applications that are now driving photonics markets, including industrial processing, optical
communications, defense, life sciences, and semiconductors. They will discuss the competitive landscape for optics and
laser manufacturers, and the opportunities for new technologies and products. And they will also visit subjects such as
II-VI’s long-term growth strategy, including acquisitions and global markets.
Light Wave Advisors
Abstract: The business and investment environment for photonics companies is fragmented and competitive, and presents
a healthy overall fnancial picture that obscures the dynamics of each niche market and each company serving that market.
John Dexheimer, a long-time investor, advisor, and board member of photonics companies, will present his analysis of the
real state of affairs relative to the valuations of public and private companies, and what these valuations might mean for
executives and investors in photonics. His goal is to provide a behind the scenes, real-world view of deal/price
evolutions —including the good, bad, ugly outcomes—and how to work the market and personal dynamics that
executives and investors will face.
Praveen Arany DDS, PhD
Assistant Professor, Oral Biology & Biomedical Engineering
School of Dental Medicine, Engineering & Applied Sciences
University at Buffalo
Abstract: Photobiomodulation (PBM) therapy is revolutionizing health care, with new applications varying from hair
regrowth to treating post-traumatic stress disorder (PTSD) and quickly healing wounds. Researchers and investors are
beginning to understand the biological mechanisms involved and the potential to transform health care. Dr. Praveen Arany
is a leading researcher in this feld. Besides being the immediate past-president of the North American Association for
Photobiomodulation Therapy and current president-elect of the World Association for Laser Therapy, he plays key roles in
promoting PBM therapy in SPIE and OSA. His roles have provided much insight into both the underlying science and the
growing market opportunities. His talk will include a discussion of existing and potential applications, market size, and
companies in the feld. He will also present a wish list of photonics devices that could advance the feld, and a view of
where it will be in a few years.